ACTU

ACTU

USD

Actuate Therapeutics Inc. Common stock

$6.590+0.090 (1.385%)

Цена в режиме реального времени

Healthcare
Биотехнология
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$6.500

Максимум

$6.660

Минимум

$6.461

Объем

0.02M

Фундаментальные показатели компании

Рыночная капитализация

153.2M

Отрасль

Биотехнология

Страна

United States

Статистические данные торговли

Средний объем

0.07M

Биржа

NGM

Валюта

USD

52-недельный диапазон

Минимум $5.47Текущая $6.590Максимум $11.99

Связанные новости

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Actuate Therapeutics, Maintains $20 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Actuate Therapeutics with a Buy and maintains $20 price target.

Просмотреть больше
HC Wainwright & Co. Reiterates Buy on Actuate Therapeutics, Maintains $20 Price Target
GlobeNewswire

Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months

Elraglusib represents a potential back bone therapy in pancreatic cancer with three ongoing trials in combination with current standards of care and novel immunotherapiesRecent financing provides extended runway through

Просмотреть больше
Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months
GlobeNewswire

Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option

CHICAGO and FORT WORTH, Texas, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ:ACTU) ("Actuate" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for

Просмотреть больше
Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
GlobeNewswire

Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock

CHICAGO and FORT WORTH, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ:ACTU) ("Actuate" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for

Просмотреть больше
Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
GlobeNewswire

Actuate Therapeutics Announces Proposed Public Offering of Common Stock

CHICAGO and FORT WORTH, Texas, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ:ACTU) ("Actuate" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for

Просмотреть больше
Actuate Therapeutics Announces Proposed Public Offering of Common Stock

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.